HuGE Literature Finder
Records
1
-
5
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders. British journal of haematology 2019 7 187 (4): 441-446. Varettoni Marzia, Zibellini Silvia, Boveri Emanuela, Klersy Catherine, Candido Chiara, Rattotti Sara, Ferretti Virginia V, Defrancesco Irene, Mangiacavalli Silvia, Nizzoli Maria E, Flospergher Elena, Zerbi Caterina, Bergamini Fabio, Benvenuti Pietro, Brociner Marco, Merati Gabriele, Paulli Marco, Arcaini Lu |
Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma. Haematologica 2017 7 102 (10): 1758-1766. Jallades Laurent, Baseggio Lucile, Sujobert Pierre, Huet Sarah, Chabane Kaddour, Callet-Bauchu Evelyne, Verney Aurélie, Hayette Sandrine, Desvignes Jean-Pierre, Salgado David, Levy Nicolas, Béroud Christophe, Felman Pascale, Berger Françoise, Magaud Jean-Pierre, Genestier Laurent, Salles Gilles, Traverse-Glehen Alexand |
MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Jan . Rovira Jordina, Karube Kennosuke, Valera Alexandra, Colomer Dolors, Enjuanes Anna, Colomo Luis, Martinez-Trillos Alexandra, Gine Eva, Dlouhy Ivan, Magnano Laura, Delgado Julio, Martinez Antonio, Villamor Neus, Campo Elias, Lopez-Guillermo Arman |
MYD88 L265P somatic mutation: its usefulness in the differential diagnosis of bone marrow involvement by B-cell lymphoproliferative disorders. American journal of clinical pathology 2013 Sep 140 (3): 387-94. Ondrejka Sarah L, Lin Jeffrey J, Warden Doug W, Durkin Lisa, Cook James R, Hsi Eric |
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood 2013 Jan . Varettoni M, Arcaini L, Zibellini S, Boveri E, Rattotti S, Riboni R, Corso A, Orlandi E, Bonfichi M, Gotti M, Pascutto C, Mangiacavalli S, Croci G, Fiaccadori V, Morello L, Guerrera ML, Paulli M, Cazzola M |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 21, 2023
- Content source: